Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity

Neurological Sciences

Volumn 32, Issue 4, 2011, Pages 547-550

  Errichiello, Luca ^a   Striano, Salvatore ^a   Zara, Federico ^b   Striano, Pasquale ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Anti glutamic acid decarboxylase antibodies; Autoimmunity; Epilepsy; Temporal lobe epilepsy

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; METHYLPREDNISOLONE;

AUTOIMMUNITY; DISEASE ASSOCIATION; EPILEPTOGENESIS; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PATHOGENICITY; PATHOPHYSIOLOGY; PHENOTYPE; REMISSION; REVIEW; SEIZURE; SEIZURE SUSCEPTIBILITY; TEMPORAL LOBE EPILEPSY;

ANIMALS; ANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; EPILEPSY; EPILEPSY, TEMPORAL LOBE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS;

EID: 80053943183     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-011-0566-8     Document Type: Review

References (39)

1. Cascino GD (2008) When drugs and surgery don't work. Epilepsia 49(Suppl 9):79-84
2. Sander JW (2003) The epidemiology of epilepsy revisited. Curr Opin Neurol 16(2):165-170 (Pubitemid 36521202)
3. Semah F, Picot MC, Adam C, Broglin D, Arzimanoglou A, Bazin B, Cavalcanti D, Baulac M (1998) Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 51(5):1256-1262 (Pubitemid 28520540)
4. Kwan P, Brodie MJ (2003) Clinical trials of antiepileptic medications in newly diagnosed patient with epilepsy. Neurology 60(11 Suppl 4):S2-S12 (Pubitemid 36736307)
5. + Eur J Paediatr Neurol 9(1):29-42 (Pubitemid 40214769)
6. Bernasconi P, Cipelletti B, Passerini L, Granata T, Antozzi C, Mantegazza R, Spreafico R (2002) Similar binding to glutamate receptors by Rasmussen and partial epilepsy patients' sera. Neurology 59(12):1998-2001 (Pubitemid 36076583)
7. van Engelen BG, Renier WO, Weemaes CM, Gabreels FJ, Meinardi H (1994) Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Res 19(3):181-190
8. Saiz A, Blanco Y, Sabater L,González F, Bataller L,Casamitjana R, Ramió-Torrentà L, Graus F (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131(Pt 10):2553-2563
9. Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Keränen T, Graus F (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55(1):46-50 (Pubitemid 30460996)
10. Giometto B, Nicolao P, Macucci M, Tavolato B, Foxon R, Bottazzo GF (1998) Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 352:457 (Pubitemid 28362802)
11. Errichiello L, Perruolo G, Pascarella A, Formisano P, Minetti C, Striano S, Zara F, Striano P (2009) Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol 211(1-2):120-123
12. Liimatainen S, Peltola M, Sabater L, Fallah M, Kharazmi E, Haapala AM, Dastidar P, Knip M, Saiz A, Peltola J (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51(5):760-767
13. Sokol DK, McIntyre JA, Wagenknecht DR, Dropcho EJ, Patel H, Salanova V, da Costa G (2004) Antiphospholipid and glutamic acid decarboxylase antibodies in patients with focal epilepsy. Neurology 62(3):517-518 (Pubitemid 38200881)
14. Irani SR, Bien CG, Lang B (2011) Autoimmune epilepsies. Curr Opin Neurol 24(2):146-153
15. Faulkner-Jones BE, Cram DS, Kun J, Harrison LC (1993) Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic beta-cells and other peripheral tissues of mouse and rat. Endocrinology 133(6):2962-2972 (Pubitemid 24000760)
16. Bu DF, Tobin AJ (1994) The exon-intron organization of the genes encoding two human glutamate decarboxylases (GAD65 and GAD 67) suggests that they derive from a common ancestral GAD. Genomics 21:222-228 (Pubitemid 24157747)
17. Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Kanbara N, Kuzume H, Sanbo M, Yagi T, Obata K (1997) Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94(12):6496-6499 (Pubitemid 27270713)
18. Hong J, Heng W, Gregory O, Jianning W, Kathleen D, Di S, Eric F, Che-Chang H, Richard DK, Jang-Yen W (2003) Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. PNAS 100:4293-4298
19. Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, Baekkeskov S (1997) Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94(25):14060-14065 (Pubitemid 28009709)
20. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 322:1555-1560 (Pubitemid 20176695)
21. Espay AJ, Chen R (2006) Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle Nerve 34(6):677-690 (Pubitemid 44877552)
22. Dalakas MC, Fujii M, Li M, McElroy B (2000) The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 55:1531-1535
23. Sperber EF, Velísková J, Germano IM, Friedman LK, Moshé SL (1999) Age-dependent vulnerability to seizures. Adv Neurol 79:161-169
24. Lloyd KG, Scatton B, Voltz C, Bryere P, Valin A, Naquet R (1986) Cerebrospinal fluid amino acid and monoamine metabolite levels of Papio papio: correlation with photosensitivity. Brain Res 363(2):390-394 (Pubitemid 16146293)
25. Esclapez M, Trottier S (1989) Changes in GABA-immunoreactive cell density during motor focal epilepsy induced by cobalt in the rat. Exp Brain Res 76(2):369-385 (Pubitemid 19180462)
26. Fritsch B, Qashu F, Figueiredo TH, Aroniadou-Anderjaska V, Rogawski MA, Braga MF (2009) Pathological alterations in GABAergic interneurons and reduced tonic inhibition in the basolateral amygdala during epileptogenesis. Neuroscience 163(1):415-429
27. Treiman DM (2001) GABAergic mechanisms in epilepsy. Epilepsia 42(Suppl 3):8-12 (Pubitemid 32781374)
28. Macdonald RL, Kelly KM (1995) Antiepileptic drug mechanisms of action. Epilepsia 36(Suppl 2):S2-S12
29. Vianello M, Tavolato B, Giometto B (2002) Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci 23:145-151 (Pubitemid 35345488)
30. Aykutlu E, Baykan B, Gürses C, Gokyigit A, Saruhan-Direskeneli G (2005) No association of anti-GM1 and anti-GAD antibodies with juvenile myoclonic epilepsy: a pilot study. Seizure 14(5):362-366 (Pubitemid 40916321)
31. Striano P, Perruolo G, Errichiello L, Formisano P, Beguinot F, Zara F, Striano S (2008) Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes. Ann Neurol 63:127-128 (Pubitemid 351240564)
32. Striano P, Errichiello L, Striano S (2011) Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance? Epilepsy Behav 20:145
33. Levy LM, Levy-Reis I, Fujii M, Dalakas MC (2005) Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol 62(6):970-974 (Pubitemid 40973459)
34. Fishman PS, Drachman DB (1995) Internalization of IgG in motoneurons of patients with ALS: selective or nonselective? Neurology 45(8):1551-1554
35. Vianello M, Bisson G, Dal Maschio M, Vassanelli S, Girardi S, Mucignat C, Fountzoulas K, Giometto B (2008) Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies. Autoimmunity 41(1):66-73
36. Vianello M, Keir G, Giometto B, Betterle C, Tavolato B, Thompson EJ (2005) Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies. Eur J Neurol 12:294-299 (Pubitemid 40480981)
37. Vianello M, Giometto B, Vassanelli S, Canato M, Betterle C, Mucignat C (2006) Peculiar labeling of cultured hippocampal neurons by different sera harbouring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab). Exp Neurol 202:514-518 (Pubitemid 44692680)
38. Kanter IC, Huttner HB, Staykov D, Biermann T, Struffert T, Kerling F, Hilz MJ, Schellinger PD, Schwab S, Bardutzky J (2008) Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 49(5):914-920 (Pubitemid 351652431)
39. Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, Bisulli F, Paganini M, Mazzi G, Sorbi S, Tinuper P (2008) Nonparaneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol 199(1-2):155-159